Genetic Technologies Ltd (GENE) — Cash Flow Reinvestment Rate
Genetic Technologies Ltd (GENE) has a Cash Flow Reinvestment Rate of 0.06x as of June 2011, reinvesting $69.84K (capex $69.84K ) from operating cash flow of $1.12 Million. See Genetic Technologies Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Genetic Technologies Ltd Cash Flow Reinvestment Rate (2007–2011)
Historical reinvestment intensity for Genetic Technologies Ltd across 3 annual periods. For the full cash flow conversion analysis, see GENE cash flow conversion.
Annual Cash Flow Reinvestment Rate for Genetic Technologies Ltd (2007–2011)
Year-by-year capital reinvestment analysis for Genetic Technologies Ltd. See financial flexibility index of Genetic Technologies Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2011 | 0.06x | $139.68K | $2.23 Million | $139.68K | ▼ -77.6% |
| 2008 | 0.28x | $118.26K | $423.68K | $118.26K | ▲ +286.6% |
| 2007 | 0.07x | $158.87K | $2.20 Million | $158.87K | — |